{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:02:57Z","timestamp":1789581777279,"version":"build-2803163510"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>In a mechanistic substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) randomized clinical trial, pitavastatin reduced noncalcified plaque (NCP) volume, but specific protein and gene pathways contributing to changes in coronary plaque remain unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To use targeted discovery proteomics and transcriptomics approaches to interrogate biological pathways beyond low-density lipoprotein cholesterol (LDL-C), relating statin outcomes to reduce NCP volume and promote plaque stabilization among people with HIV (PWH).<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This was a post hoc analysis of the double-blind, placebo-controlled, REPRIEVE randomized clinical trial. Participants underwent coronary computed tomography angiography (CTA), plasma protein analysis, and transcriptomic analysis at baseline and 2-year follow-up. The trial enrolled PWH from April 2015 to February 2018 at 31 US research sites. PWH without known cardiovascular diseases taking antiretroviral therapy and with low to moderate 10-year cardiovascular risk were eligible. Data analyses were conducted from October 2023 to February 2024.<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention<\/jats:title><jats:p>Oral pitavastatin calcium, 4 mg per day.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Relative change in plasma proteomics, transcriptomics, and noncalcified plaque volume among those receiving treatment vs placebo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 558 individuals (mean [SD] age, 51 [6] years; 455 male [82%]) included in the proteomics assessment, 272 (48.7%) received pitavastatin and 286 (51.3%) received placebo. After adjusting for false discovery rates, pitavastatin increased abundance of procollagen C-endopeptidase enhancer 1 (PCOLCE), neuropilin 1 (NRP-1), major histocompatibility complex class I polypeptide-related sequence A (MIC-A) and B (MIC-B), and decreased abundance of tissue factor pathway inhibitor (TFPI), tumor necrosis factor ligand superfamily member 10 (TRAIL), angiopoietin-related protein 3 (ANGPTL3), and mannose-binding protein C (MBL2). Among these proteins, the association of pitavastatin with PCOLCE (a rate-limiting enzyme of collagen deposition) was greatest, with an effect size of 24.3% (95% CI, 18.0%-30.8%; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). In a transcriptomic analysis, individual collagen genes and collagen gene sets showed increased expression. Among the 195 individuals with plaque at baseline (88 [45.1%] taking pitavastatin, 107 [54.9%] taking placebo), changes in NCP volume were most strongly associated with changes in PCOLCE (%change NCP volume\/log<jats:sub>2<\/jats:sub>-fold change\u2009=\u2009\u221231.9%; 95% CI, \u221242.9% to \u221218.7%; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), independent of changes in LDL-C level. Increases in PCOLCE related most strongly to change in the fibro-fatty (&amp;amp;lt;130 Hounsfield units) component of NCP (%change fibro-fatty volume\/log<jats:sub>2<\/jats:sub>-fold change\u2009=\u2009\u221238.5%; 95% CI, \u221258.1% to \u22129.7%; <jats:italic>P<\/jats:italic>\u2009=\u2009.01) with a directionally opposite, although nonsignificant, increase in calcified plaque (%change calcified volume\/log<jats:sub>2<\/jats:sub>-fold change\u2009=\u200934.4%; 95% CI, \u22127.9% to 96.2%; <jats:italic>P<\/jats:italic>\u2009=\u2009.12).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Relevance<\/jats:title><jats:p>Results of this secondary analysis of the REPRIEVE randomized clinical trial suggest that PCOLCE may be associated with the atherosclerotic plaque stabilization effects of statins by promoting collagen deposition in the extracellular matrix transforming vulnerable plaque phenotypes to more stable coronary lesions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT02344290\">NCT02344290<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamacardio.2024.4115","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T20:27:48Z","timestamp":1733948868000},"page":"254","source":"Crossref","is-referenced-by-count":18,"title":["Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV"],"prefix":"10.1001","volume":"10","author":[{"given":"M\u00e1rton","family":"Kolossv\u00e1ry","sequence":"first","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Schnittman","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Division of Infectious Diseases, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markella V.","family":"Zanni","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen V.","family":"Fitch","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Fichtenbaum","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Aberg","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald S.","family":"Bloomfield","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke Global Health Institute, Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos D.","family":"Malvestutto","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Ohio State University Medical Center, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Currier","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa R.","family":"Diggs","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"deFilippi","sequence":"additional","affiliation":[{"name":"Inova Schar Heart and Vascular, Falls Church, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison Ross","family":"Eckard","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Medicine, Divisions of Infectious Diseases, Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Curran","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Vall d\u2019Hebron Research Institute, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Centinbas","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Massachusetts General Hospital, Boston"},{"name":"Department of Genetics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan","family":"Sadreyev","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Massachusetts General Hospital, Boston"},{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borek","family":"Foldyna","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mayrhofer","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Karady","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Cardiovascular Imaging Research Group, Heart and Vascular Center, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Taron","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Massachusetts General Hospital, Boston"},{"name":"Department of Radiology, Medical Center \u2013 University of Freiburg, Faculty of Medicine, University of Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"McCallum","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Lu","sequence":"additional","affiliation":[{"name":"Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J.","family":"Ribaudo","sequence":"additional","affiliation":[{"name":"Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela S.","family":"Douglas","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.","family":"Grinspoon","sequence":"additional","affiliation":[{"name":"Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"hoi240068r1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction.","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"6","key":"hoi240068r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14923","article-title":"Assessment of coronary artery disease with computed tomography angiography and inflammatory and immune activation biomarkers among adults with HIV eligible for primary cardiovascular prevention.","volume":"4","author":"Hoffmann","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"hoi240068r3","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1097\/QAD.0b013e32835eca9b","article-title":"Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men.","volume":"27","author":"Zanni","year":"2013","journal-title":"AIDS"},{"issue":"18","key":"hoi240068r4","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","article-title":"Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish Computed Tomography of the HEART).","volume":"141","author":"Williams","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"hoi240068r5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to prevent cardiovascular disease in HIV infection.","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N Engl J Med"},{"issue":"17","key":"hoi240068r6","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1056\/NEJMc2400870","article-title":"Trial Update of Pitavastatin to Prevent Cardiovascular Events in HIV Infection.","volume":"390","author":"Grinspoon","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"hoi240068r7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1001\/jamacardio.2023.5661","article-title":"Effects of pitavastatin on coronary artery disease and inflammatory biomarkers in HIV: mechanistic substudy of the REPRIEVE randomized clinical trial.","volume":"9","author":"Lu","year":"2024","journal-title":"JAMA Cardiol"},{"key":"hoi240068r8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ahj.2018.12.016","article-title":"Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).","volume":"212","author":"Grinspoon","year":"2019","journal-title":"Am Heart J"},{"key":"hoi240068r9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2019.02.011","article-title":"Rationale and design of the mechanistic substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): effects of pitavastatin on coronary artery disease and inflammatory biomarkers.","volume":"212","author":"Hoffmann","year":"2019","journal-title":"Am Heart J"},{"issue":"6","key":"hoi240068r10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/infdis\/jiaa196","article-title":"Differential plasma protein regulation and statin effects in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients utilizing a proteomics approach.","volume":"222","author":"deFilippi","year":"2020","journal-title":"J Infect Dis"},{"issue":"10","key":"hoi240068r11","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1093\/infdis\/jiac196","article-title":"Proteomic signature of subclinical coronary artery disease in people with HIV: analysis of the REPRIEVE mechanistic substudy.","volume":"226","author":"Kolossv\u00e1ry","year":"2022","journal-title":"J Infect Dis"},{"issue":"21","key":"hoi240068r12","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.120.045810","article-title":"Proteomic evaluation of the comorbidity-inflammation paradigm in heart failure with preserved ejection fraction: results from the PROMIS-HFpEF study.","volume":"142","author":"Sanders-van Wijk","year":"2020","journal-title":"Circulation"},{"key":"hoi240068r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104538","article-title":"Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV.","volume":"90","author":"Kolossv\u00e1ry","year":"2023","journal-title":"EBioMedicine"},{"issue":"7","key":"hoi240068r14","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jcmg.2010.04.011","article-title":"Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention.","volume":"3","author":"Inoue","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"22","key":"hoi240068r15","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.jacc.2018.02.079","article-title":"Coronary atherosclerotic precursors of acute coronary syndromes.","volume":"71","author":"Chang","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"hoi240068r16","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.jcmg.2018.04.015","article-title":"Effects of statins on coronary atherosclerotic plaques: the PARADIGM study.","volume":"11","author":"Lee","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"hoi240068r17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner.","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"2","key":"hoi240068r18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2013a Python framework to work with high-throughput sequencing data.","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"issue":"1","key":"hoi240068r19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"issue":"25","key":"hoi240068r20","doi-asserted-by":"publisher","first-page":"e1046","DOI":"10.1161\/CIR.0000000000000624","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines.","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"9753","key":"hoi240068r21","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials.","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"23","key":"hoi240068r22","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1001\/jama.2012.6571","article-title":"Lipid-related markers and cardiovascular disease prediction.","volume":"307","author":"Di Angelantonio","year":"2012","journal-title":"JAMA"},{"issue":"7","key":"hoi240068r23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/QAD.0000000000001762","article-title":"Novel mediators of statin effects on plaque in HIV: a proteomics approach.","volume":"32","author":"deFilippi","year":"2018","journal-title":"AIDS"},{"key":"hoi240068r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2022.104788","article-title":"A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study.","volume":"272","author":"Bohn","year":"2023","journal-title":"J Proteomics"},{"issue":"1","key":"hoi240068r25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2011.11.002","article-title":"Mannan-binding lectin deficiency\u2014good news, bad news, doesn\u2019t matter?","volume":"143","author":"Heitzeneder","year":"2012","journal-title":"Clin Immunol"},{"issue":"3","key":"hoi240068r26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease.","volume":"377","author":"Dewey","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"hoi240068r27","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.3390\/ijms24076725","article-title":"The prognostic, diagnostic, and therapeutic potential of TRAIL signaling in cardiovascular diseases.","volume":"24","author":"Kelland","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"hoi240068r28","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000967","article-title":"Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy.","volume":"8","author":"Chuckran","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"5428","key":"hoi240068r29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"issue":"3","key":"hoi240068r30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/EBC20180049","article-title":"Roles of the procollagen C-propeptides in health and disease.","volume":"63","author":"Hulmes","year":"2019","journal-title":"Essays Biochem"},{"issue":"7","key":"hoi240068r31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0945-053X(98)90013-0","article-title":"Procollagen N-proteinase and procollagen C-proteinase: 2 unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signaling.","volume":"16","author":"Prockop","year":"1998","journal-title":"Matrix Biol"},{"issue":"6","key":"hoi240068r32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/FJC.0000000000001359","article-title":"Role of collagen in vascular calcification.","volume":"80","author":"Zhao","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"hoi240068r33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/CIRCRESAHA.122.321538","article-title":"TXNIP suppresses the osteochondrogenic switch of vascular smooth muscle cells in atherosclerosis.","volume":"132","author":"Woo","year":"2023","journal-title":"Circ Res"},{"issue":"11","key":"hoi240068r34","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1001\/jamacardio.2021.3055","article-title":"Association of statin treatment with progression of coronary atherosclerotic plaque composition.","volume":"6","author":"van Rosendael","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"7","key":"hoi240068r35","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/01.CIR.103.7.993","article-title":"Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits.","volume":"103","author":"Fukumoto","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"hoi240068r36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jcct.2018.05.004","article-title":"Improvement in LDL is associated with decrease in non-calcified plaque volume on coronary CTA as measured by automated quantitative software.","volume":"12","author":"Tamarappoo","year":"2018","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"hoi240068r37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2019.04.201","article-title":"Decrease in LDL-C is associated with decrease in all components of noncalcified plaque on coronary CTA.","volume":"285","author":"Otaki","year":"2019","journal-title":"Atherosclerosis"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2827835\/jamacardiology_kolossvry_2024_oi_240068_1741367275.30986.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:01:35Z","timestamp":1741791695000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2827835"}},"subtitle":["A Secondary Analysis of the REPRIEVE Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2024.4115","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,1]]}}}